Sunshine Biopharma, Inc.

SBFMNASDAQHealthcare● Active

$2.43

$-0.03(-1.22%)

Market Cap$1216409

P/E Ratio—

52W High$24.3

52W Low$2.11

Avg Volume1.6M

Open$2.46

Beta1.29

Overview

Sunshine Biopharma, Inc. (SBFM) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SBFM · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Sunshine Biopharma, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

SBFM insider buying and selling by quarter

SBFM insider selling · SBFM insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

60.0M30.0M0

2021 Q1

2021 Q4

2022 Q1

2022 Q2

2022 Q4

2024 Q1

2025 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · SBFM ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SBFM executive sell shares · SBFM board member insider trading · SBFM insider trading SEC filing

Showing 43 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Apr 14, 2026	NATAN DAVID Director	Award	100,000	—	—	100,000	Form 4
Nov 30, 2022	Sebaaly Camille CFO/Secretary	Purchase	30,000	$0.76	$23K	174,465	Form 4
Jun 3, 2022	Sebaaly Camille CFO/Secretary	Purchase	25,000	$1.22	$31K	144,465	Form 4
Jan 6, 2021	MERZOUKI ABDERRAZZAK COO · Director	Award	20,000,000	$0.00	$20K	23,342,500	Form 4
Jan 6, 2021	Slilaty Steve N. CEO · Director	Award	20,000,000	$0.00	$20K	23,343,461	Form 4
Jan 6, 2021	Sebaaly Camille CFO/Secretary · Director	Award	20,000,000	$0.00	$20K	23,893,086	Form 4
Dec 19, 2019	Sebaaly Camille CFO/Secretary · Director	Award	1,300,000	$0.00	$1K	3,893,086	Form 4
Oct 20, 2019	Sebaaly Camille CFO/Secretary · Director	Award	1,100,000	$0.00	$1K	2,593,086	Form 4
Sep 11, 2019	Sebaaly Camille CFO/Secretary · Director	Award	550,000	$0.00	$550	1,493,086	Form 4
Dec 31, 2019	Sebaaly Camille CFO/Secretary · Director	Award	323,673	$0.00	$324	0	Form 4
Dec 19, 2019	MERZOUKI ABDERRAZZAK COO · Director	Award	1,300,000	$0.00	$1K	3,342,500	Form 4
Oct 20, 2019	MERZOUKI ABDERRAZZAK COO · Director	Award	1,100,000	$0.00	$1K	2,042,500	Form 4
Dec 19, 2019	Slilaty Steve N. CEO · Director	Award	1,300,000	$0.00	$1K	3,343,461	Form 4
Oct 20, 2019	Slilaty Steve N. CEO · Director	Award	1,100,000	$0.00	$1K	2,043,461	Form 4
Dec 31, 2019	Slilaty Steve N. CEO · Director	Other	323,673	$0.00	$324	861,209	Form 4
Sep 2, 2019	MERZOUKI ABDERRAZZAK COO · Director	Award	13,000,000	$0.00	$13K	18,850,000	Form 4
Sep 11, 2019	Sebaaly Camille Secretary · Director	Award	11,000,000	$0.00	$11K	29,861,719	Form 4
Sep 2, 2019	Sebaaly Camille Secretary · Director	Award	13,000,000	$0.00	$13K	18,861,719	Form 4
Sep 2, 2019	Slilaty Steve N. CEO · Director	Award	13,000,000	$0.00	$13K	18,869,219	Form 4
Aug 27, 2018	MERZOUKI ABDERRAZZAK COO · Director	Award	38,000,000	$0.00	$38K	118,467,000	Form 4
Aug 27, 2018	Sebaaly Camille Secretary · Director	Award	38,000,000	$0.00	$38K	117,234,373	Form 4
Aug 27, 2018	Slilaty Steve N. CEO · Director	Award	38,000,000	$0.00	$38K	117,384,373	Form 4
Jun 20, 2018	MERZOUKI ABDERRAZZAK COO · Director	Award	27,000,000	$0.00	$27K	80,467,000	Form 4
Jun 20, 2018	Sebaaly Camille Secretary · Director	Award	27,000,000	$0.00	$27K	79,234,373	Form 4
Jun 20, 2018	Slilaty Steve N. CEO · Director	Award	27,000,000	$0.00	$27K	79,384,373	Form 4

NATAN DAVID

Director

Award

Date

Apr 14

100,000

Price

—

Value

—

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary

Purchase

Date

Nov 30

30,000

Price

$0.76

Value

$23K

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary

Purchase

Date

Jun 3

25,000

Price

$1.22

Value

$31K

View Form 4 on SEC.gov

MERZOUKI ABDERRAZZAK

COO · Director

Award

Date

Jan 6

20,000,000

Price

$0.00

Value

$20K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Award

Date

Jan 6

20,000,000

Price

$0.00

Value

$20K

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary · Director

Award

Date

Jan 6

20,000,000

Price

$0.00

Value

$20K

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary · Director

Award

Date

Dec 19

1,300,000

Price

$0.00

Value

$1K

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary · Director

Award

Date

Oct 20

1,100,000

Price

$0.00

Value

$1K

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary · Director

Award

Date

Sep 11

550,000

Price

$0.00

Value

$550

View Form 4 on SEC.gov

Sebaaly Camille

CFO/Secretary · Director

Award

Date

Dec 31

323,673

Price

$0.00

Value

$324

View Form 4 on SEC.gov

MERZOUKI ABDERRAZZAK

COO · Director

Award

Date

Dec 19

1,300,000

Price

$0.00

Value

$1K

View Form 4 on SEC.gov

MERZOUKI ABDERRAZZAK

COO · Director

Award

Date

Oct 20

1,100,000

Price

$0.00

Value

$1K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Award

Date

Dec 19

1,300,000

Price

$0.00

Value

$1K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Award

Date

Oct 20

1,100,000

Price

$0.00

Value

$1K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Other

Date

Dec 31

323,673

Price

$0.00

Value

$324

View Form 4 on SEC.gov

MERZOUKI ABDERRAZZAK

COO · Director

Award

Date

Sep 2

13,000,000

Price

$0.00

Value

$13K

View Form 4 on SEC.gov

Sebaaly Camille

Secretary · Director

Award

Date

Sep 11

11,000,000

Price

$0.00

Value

$11K

View Form 4 on SEC.gov

Sebaaly Camille

Secretary · Director

Award

Date

Sep 2

13,000,000

Price

$0.00

Value

$13K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Award

Date

Sep 2

13,000,000

Price

$0.00

Value

$13K

View Form 4 on SEC.gov

MERZOUKI ABDERRAZZAK

COO · Director

Award

Date

Aug 27

38,000,000

Price

$0.00

Value

$38K

View Form 4 on SEC.gov

Sebaaly Camille

Secretary · Director

Award

Date

Aug 27

38,000,000

Price

$0.00

Value

$38K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Award

Date

Aug 27

38,000,000

Price

$0.00

Value

$38K

View Form 4 on SEC.gov

MERZOUKI ABDERRAZZAK

COO · Director

Award

Date

Jun 20

27,000,000

Price

$0.00

Value

$27K

View Form 4 on SEC.gov

Sebaaly Camille

Secretary · Director

Award

Date

Jun 20

27,000,000

Price

$0.00

Value

$27K

View Form 4 on SEC.gov

Slilaty Steve N.

CEO · Director

Award

Date

Jun 20

27,000,000

Price

$0.00

Value

$27K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SBFM insider trading

SBFM insider trades

Sunshine Biopharma, Inc. (SBFM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including NATAN DAVID (Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. SBFM insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Sunshine Biopharma, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

SBFM insider trading · 5 questions

The insiders of Sunshine Biopharma, Inc. (SBFM) include executives and directors such as NATAN DAVID (Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SBFM board member insider tradingwho are SBFM insidersSBFM insider rosterSunshine Biopharma, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026